Serum Institute resumes COVID-19 vaccine exports

November 26, 2021 18:34

Serum Institute of India -- the world's largest vaccine maker -- on Friday said it has resumed exports of Covishield vaccine to low- and middle-income countries with the first batch of consignment leaving its Pune facility.

The vaccine maker has cumulatively produced 1.25 billion doses so far, a company statement said.

"The first batches of its COVISHIELD COVID-19 vaccine left the SII manufacturing facility in Pune earlier today, for distribution to low- and middle-income countries via the COVAX mechanism," it said.

"SII's supply of doses via COVAX is expected to increase substantially into Quarter 1 2022," it added.

« Back to LIVE

TOP STORIES

Sensex revisits 74K; Nifty climbs 168 points

State Bank of India, NTPC, Nestle, Sun Pharma, JSW Steel, ITC, Mahindra & Mahindra and HCL Technologies were among the other major gainers.

Date Night For Aditi-Siddharth

The who's who of Bollywood made sure to attend Sanjay Leela Bhansali's magnum opus Web series, Heeramandi: The Diamond Bazaar.

Recipe: Richard Holkar's Murgi Survedar

This recipe has a wonderful royal touch.

SC to share case info with advocates through WhatsApp

The announcement on integration of WhatsApp with its Information and Communications Technology (ICT) services was made by the CJI before a nine-judge bench headed by him commenced the hearing on the vexed legal question arising from the...

IPL 2024: Here's what shifted momentum in DC's favour

'Our target was 180, but Rishabh was confident and he single-handedly batted very well in the last 5 overs.'